Biotech

All Articles

ArsenalBio increases $325M, rotates away from past lead property

.Collection Biosciences is moving on up. The tissue treatment firm has added on $325 thousand in amm...

Lilly- supported weight loss biotech files IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis make use of medication fails period 2b, driving Indivior to re-think $100M alternative

.Aelis Farma's chances of safeguarding a simple, favorable decision on a $one hundred thousand alter...

ProKidney stops stage 3 trial certainly not needed for cell treatment authorization

.ProKidney has actually stopped one of a pair of phase 3 tests for its own tissue treatment for kidn...

Vaxcyte surges on 'stunning' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what professionals referred to as "remarkable" phase 1/2 information for its own 3...

Recursion's human brain illness trial shows insufficient proof of efficiency

.Recursion has actually discovered through a very early test of its tech-enabled strategy to medicin...

Acepodia, Pfizer click with each other for chemistry-based cell treatment

.Phone it a scenario of good chemistry: Acepodia, a biotech based on Nobel Prize-winning science, is...

Praxis epilepsy medicine reduces seizures in phase 2 trial

.Practice Accuracy Medicines has actually racked up one more midphase win in epilepsy this year, wit...

Three directors surrender as Dyne blog posts blended records for DMD prospect

.After running away a scientific grip many years back, Dyne Rehab has shown brand-new phase 1/2 reco...

Arrowhead fires off phase 3 records in unusual metabolic disease in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its hand before a possible showdown with Ionis, re...